Ken Griffin’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $34.9M | Sell |
392,535
-3,084,937
| -89% | -$292M | ﹤0.01% | 1927 |
|
|
2026
Q2 | $299M | Buy |
3,477,472
+2,098,807
| +152% | +$184M | 0.03% | 377 |
|
|
2026
Q1 | $125M | Buy |
1,378,665
+1,050,289
| +320% | +$96.4M | 0.02% | 676 |
|
|
2025
Q4 | $29.5M | Buy |
328,376
+212,230
| +183% | +$20.1M | ﹤0.01% | 1927 |
|
|
2025
Q3 | $11.4M | Buy |
+116,146
| New | +$11.5M | ﹤0.01% | 3075 |
|
|
2025
Q2 | – | Sell |
-2,042,564
| Closed | -$198M | – | 15445 |
|
|
2025
Q1 | $231M | Sell |
2,042,564
-363,556
| -15% | -$38.9M | 0.04% | 328 |
|
|
2024
Q4 | $254M | Buy |
2,406,120
+1,921,342
| +396% | +$206M | 0.04% | 313 |
|
|
2024
Q3 | $52.3M | Buy |
484,778
+108,295
| +29% | +$11.8M | 0.01% | 1170 |
|
|
2024
Q2 | $40.9M | Sell |
376,483
-348,834
| -48% | -$41.1M | 0.01% | 1313 |
|
|
2024
Q1 | $95.7M | Buy |
725,317
+121,769
| +20% | +$15.2M | 0.02% | 725 |
|
|
2023
Q4 | $73.5M | Sell |
603,548
-918,153
| -60% | -$102M | 0.01% | 885 |
|
|
2023
Q3 | $171M | Buy |
1,521,701
+1,455,618
| +2,203% | +$185M | 0.04% | 372 |
|
|
2023
Q2 | $9.6M | Buy |
66,083
+62,759
| +1,888% | +$8.53M | ﹤0.01% | 2730 |
|
|
2023
Q1 | $429K | Sell |
3,324
-2,328,300
| -100% | -$292M | ﹤0.01% | 8616 |
|
|
2022
Q4 | $297M | Buy |
2,331,624
+129,819
| +6% | +$15.1M | 0.07% | 207 |
|
|
2022
Q3 | $230M | Buy |
2,201,805
+2,159,222
| +5,071% | +$237M | 0.05% | 260 |
|
|
2022
Q2 | $4.47M | Buy |
+42,583
| New | +$5.05M | ﹤0.01% | 4015 |
|
|
2022
Q1 | – | Sell |
-104,155
| Closed | -$12.6M | – | 14730 |
|
|
2021
Q4 | $13.2M | Sell |
104,155
-376,755
| -78% | -$50.8M | ﹤0.01% | 2608 |
|
|
2021
Q3 | $70.4M | Buy |
480,910
+463,388
| +2,645% | +$70.2M | 0.01% | 877 |
|
|
2021
Q2 | $2.82M | Sell |
17,522
-1,245,020
| -99% | -$208M | ﹤0.01% | 5752 |
|
|
2021
Q1 | $202M | Sell |
1,262,542
-351,284
| -22% | -$56M | 0.05% | 281 |
|
|
2020
Q4 | $249M | Buy |
1,613,826
+842,291
| +109% | +$123M | 0.06% | 189 |
|
|
2020
Q3 | $105M | Sell |
771,535
-72,028
| -9% | -$9.7M | 0.03% | 439 |
|
|
2020
Q2 | $101M | Buy |
843,563
+803,960
| +2,030% | +$95.4M | 0.04% | 406 |
|
|
2020
Q1 | $4M | Sell |
39,603
-199,572
| -83% | -$26.9M | ﹤0.01% | 3029 |
|
|
2019
Q4 | $35.8M | Sell |
239,175
-681,693
| -74% | -$96.9M | 0.02% | 995 |
|
|
2019
Q3 | $126M | Buy |
920,868
+459,073
| +99% | +$61.1M | 0.06% | 296 |
|
|
2019
Q2 | $54.4M | Sell |
461,795
-1,138,796
| -71% | -$137M | 0.02% | 678 |
|
|
2019
Q1 | $204M | Buy |
1,600,591
+1,597,107
| +45,841% | +$187M | 0.1% | 140 |
|
|
2018
Q4 | $361K | Sell |
3,484
-209,844
| -98% | -$24.3M | ﹤0.01% | 6946 |
|
|
2018
Q3 | $28M | Buy |
+213,328
| New | +$26.1M | 0.01% | 1129 |
|
|
2018
Q2 | – | Sell |
-8,633
| Closed | -$968K | – | 9366 |
|
|
2018
Q1 | $941K | Sell |
8,633
-70,847
| -89% | -$8.47M | ﹤0.01% | 4910 |
|
|
2017
Q4 | $9.6M | Sell |
79,480
-240,208
| -75% | -$28M | 0.01% | 1780 |
|
|
2017
Q3 | $37.4M | Sell |
319,688
-730,119
| -70% | -$86.8M | 0.03% | 702 |
|
|
2017
Q2 | $135M | Sell |
1,049,807
-256,595
| -20% | -$31.3M | 0.11% | 154 |
|
|
2017
Q1 | $160M | Buy |
1,306,402
+810,970
| +164% | +$94.7M | 0.15% | 106 |
|
|
2016
Q4 | $51.1M | Sell |
495,432
-436,526
| -47% | -$48.2M | 0.05% | 379 |
|
|
2016
Q3 | $121M | Buy |
931,958
+461,442
| +98% | +$58.7M | 0.12% | 119 |
|
|
2016
Q2 | $56.6M | Buy |
470,516
+195,137
| +71% | +$22.7M | 0.06% | 294 |
|
|
2016
Q1 | $29.4M | Sell |
275,379
-299,363
| -52% | -$29.8M | 0.04% | 534 |
|
|
2015
Q4 | $59M | Buy |
574,742
+512,178
| +819% | +$51.6M | 0.06% | 334 |
|
|
2015
Q3 | $5.88M | Sell |
62,564
-559,172
| -90% | -$57.7M | 0.01% | 1822 |
|
|
2015
Q2 | $67.9M | Sell |
621,736
-384,497
| -38% | -$43.8M | 0.06% | 370 |
|
|
2015
Q1 | $118M | Buy |
1,006,233
+916,303
| +1,019% | +$108M | 0.11% | 183 |
|
|
2014
Q4 | $10.2M | Sell |
89,930
-33,978
| -27% | -$3.69M | 0.01% | 1406 |
|
|
2014
Q3 | $12.5M | Sell |
123,908
-758,797
| -86% | -$76.9M | 0.01% | 1227 |
|
|
2014
Q2 | $91.7M | Buy |
882,705
+718,823
| +439% | +$72.2M | 0.11% | 185 |
|
|
2014
Q1 | $15.5M | Buy |
163,882
+145,963
| +815% | +$13.9M | 0.02% | 1003 |
|
|
2013
Q4 | $1.67M | Sell |
17,919
-407,660
| -96% | -$36.3M | ﹤0.01% | 2722 |
|
|
2013
Q3 | $35M | Buy |
425,579
+343,317
| +417% | +$27.8M | 0.05% | 452 |
|
|
2013
Q2 | $6.16M | Hold |
82,262
| – | – | 0.01% | 1377 |
|
Other funds holding ZBH
Ken Griffin's ZBH Position: Q3 2026 in Review
Ken Griffin reduced its Zimmer Biomet (ZBH) stake by 89% in Q3 2026, selling an estimated $292M and leaving 392,535 shares worth $34.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.
Ken Griffin first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $299M in Q2 2026. 936 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.
- Ken Griffin held 392,535 shares of Zimmer Biomet worth $34.9M as of Q3 2026.
- Ken Griffin sold 3,084,937 Zimmer Biomet shares in Q3 2026, an estimated $292M.
- Zimmer Biomet made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1927 holding.
- Ken Griffin first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
- Ken Griffin's Zimmer Biomet position peaked at $299M in Q2 2026.
- 936 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.